rare disease therapy
-
AstraZeneca brings rare disease therapy for Indian patients
Receives regulatory approval for its molecule ‘Selumetinib’ in India AstraZeneca India announced its entry into rare disease therapy in India.…
Read More »
Receives regulatory approval for its molecule ‘Selumetinib’ in India AstraZeneca India announced its entry into rare disease therapy in India.…
Read More »